| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2004;35:1259.)
© 2004 American Heart Association, Inc.
Original Contributions |
From the Departments of Epidemiology (F.B.H, M.J.S., W.C.W., J.E.M.) and Nutrition (W.K.A.-D., F.B.H., M.J.S., W.C.W.), Harvard School of Public Health, Boston, Mass; the Channing Laboratory (K.M.R., F.B.H., M.J.S., W.C.W., J.E.M.) and the Division of Preventive Medicine (K.M.R., C.M.A., J.E.M.), Department of Medicine, Brigham and Womens Hospital; and the Cardiology Division (C.M.A.), Massachusetts General Hospital, Harvard Medical School, Boston, Mass.
Correspondence to Dr Wael K. Al-Delaimy, Department of Nutrition, Harvard School of Public Health, 665 Huntington Ave, Boston, MA 02115. E-mail wael{at}hsph.harvard.edu
| Abstract |
|---|
|
|
|---|
Methods 83 272 female nurses aged 34 to 59 years in 1980 and residing in 11 US states were followed-up for 18 years. Follow-up questionnaires were sent biennially to update information on diet and to identify newly diagnosed cases of stroke and other illnesses.
Results During 1 379 614 person-years of follow-up from 1980 to 1998, we identified 1140 incident cases of stroke. Using age-adjusted and multivariable-adjusted models, no appreciable association between the intake of folate and total incidence of stroke was observed [relative risk in the multivariable-adjusted model for the highest quintile of folate intake (median=696 µg/d) compared with the lowest quintile (median=158 µg/d) was 1.01 (95% confidence interval [CI]: 0.79 to 1.29), P for trend=0.8]. Similar null results were found in secondary analyses on stroke subtypes (ischemic, thrombotic, embolic, subarachnoid hemorrhage, intraparenchymal hemorrhage) and in analyses that separately assessed dietary folate (excluding supplement users) and folate supplement intake.
Conclusions Folate intake was not associated with incident stroke among women participating in the Nurses Health Study.
Key Words: stroke diet epidemiology
| Introduction |
|---|
|
|
|---|
Homocysteine levels depend in part on folate status: lower intake of folate leads to higher homocysteine levels.14,15 As a result of the observed inverse association between homocysteine levels and stroke, folate has been hypothesized to be protective against stroke incidence.16 Studies of serum folate or folate intake in relation to incidence of stroke have been inconsistent.1720 Therefore, we prospectively examined the association between folate intake and the risk of stroke among 83 896 women participating in the Nurses Health study who were followed-up for 18 years.
| Subjects and Methods |
|---|
|
|
|---|
Semiquantitative Food Frequency Questionnaire
In 1980, we collected data on usual dietary intake (61 items) using a validated semiquantitative food frequency questionnaire (FFQ) described elsewhere.22 In 1984, the FFQ was expanded to include 116 items. Similar questionnaires were used to update diet in 1986, 1990, and 1994. The average daily intake of nutrients was calculated by multiplying the frequency of consumption of each item by the nutrient content and totaling the nutrient intake for all food items. Nutrient intake was adjusted for total energy intake using the residual approach.23 Folic acid intake as measured on the FFQ was significantly correlated with circulating levels of folate (r=0.55)24 and predicted homocysteine, as well as serum folate levels.25 Food composition values for folate and other nutrients were obtained from the Harvard University Food Composition Database (November 22, 1993) derived from US Department of Agriculture sources26 and supplemented with manufacturer information.
Population
A total of 98 462 women returned the 1980 diet questionnaire. After excluding women who had implausibly high (>14 700 kJ/d [3500 kcal/d]) or low (<2100 kJ/d [500 kcal/d]) total energy intake, those who left 10 or more items blank, and women with cancers (excluding nonmelanoma skin cancer) or cardiovascular diseases diagnosed at baseline or before the development of stroke (during follow-up), the final population consisted of 83 896 women. We excluded women with cardiovascular or cancer diagnosis at baseline to minimize the potential bias caused by disease-induced changes in dietary habits and intake of folate.
Ascertainment of Stroke
Incident stroke occurring after the date of return of the 1980 questionnaire but before June 1, 1998 were included. Women who reported a nonfatal stroke on a follow-up questionnaire were asked for permission to review their medical records. Fatal strokes were initially ascertained by reports from relatives or postal authorities and a search of the National Death Index,27 and were then documented by medical records and death certificates. Mortality follow-up was >98% complete.27 Nonfatal or fatal strokes that were confirmed by telephone, letter, or death certificate, but for which no medical records were available, were regarded as probable. Confirmed and probable strokes were considered in the analyses for total stroke.
Strokes were confirmed by medical records according to the criteria of the National Survey of Stroke,28 which requires a constellation of neurological deficits of sudden or rapid onset lasting
24 hours or until death. Strokes were subcategorized as subarachnoid hemorrhages, intraparenchymal hemorrhages, thrombotic, embolic, or ischemic (which includes thrombotic, embolic, and nonhemorrhagic strokes).
Data Analysis
We computed person-time of follow-up for each participant from the return date of the 1980 questionnaire to the date of stroke diagnosis, to the day of death from any cause, or January 31, 1998, whichever came first. Women who reported CVD on previous questionnaires were excluded from subsequent follow-up; thus, each participant could contribute only 1 end point.
The incidence rate for each category of folate was calculated as the number of cases with stroke divided by the person-time of follow-up. Total and dietary folate intake variables were energy-adjusted, but folate supplement intake was not. Cutoff points for total and dietary folate intake (excluding supplements) were obtained by dividing each into quintiles. We categorized folate supplement intake into 4 categories that approximately resembled the quartiles of folate supplement intake levels among our population (0.1 to 149 µg/d, 150 to 249 µg/d, 250 to 399 µg/d,
400 µg/d), and women who did not report supplement use served as the reference category in the analysis. To adjust for covariates, we used pooled logistic regression,29 pooling over each 2-year period using SAS statistical software version 6.12,30 that is asymptotically equivalent to the Cox regression model with time-dependent covariates, given short time intervals and low probability of the outcome within the interval, as in this study.
Exposure categories were updated every 2 years in all analyses. In multivariable analyses, CVD risk factors were included in the model (see Table 1 footnote). We conducted further analyses to adjust for dietary variables that are related to risk of stroke, including specific fatty acids, protein, and cereal fiber.
|
Because of the long follow-up period, dietary variables were updated and the cumulative average of nutrient intake was calculated from the dietary questionnaires administered in 1980, 1984, 1986, 1990, and 1994. Incident cases of stroke documented between each diet questionnaire cycle were examined in relation to the average diet calculated from all the preceding diet measures. Cumulative averaging reduces within-person variation and thus can better represent long-term intake.31 In secondary analyses, we used simple updated intake of folate (updated to the most recent questionnaire) to assess short-term exposure. Because change in diet after development of intermediate conditions such as angina, hypercholesterolemia, and diabetes may confound the exposuredisease association, we stopped updating diet and covariates at the beginning of the time interval during which individuals developed those intermediate end points. Excluding hypercholesterolemia and diabetes at baseline did not change the results.
Mantel extension tests for trend32 were obtained by assigning the median value for each category and modeling this as a continuous variable. All P values are 2-sided.
| Results |
|---|
|
|
|---|
Table I (available online at http://stroke.ahajournals.org) shows the characteristics of our study population at baseline according to folate quintiles. The age-adjusted models for total stroke (fatal and nonfatal) suggested a significant protective trend (Table 1). However, these became close to null and the trends became nonsignificant in the multivariable-adjusted models. In multivariable analyses, folate intake was also not significantly associated with specific subtypes of stroke (Table 2). Further analyses using simple update of folate intake during follow-up did not change the overall conclusions.
|
|
Dietary folate intake (excluding supplements) and folate supplement intake were not significantly related to risk of stroke (Table II; available online at http://stroke.ahajournals.org). There was no significant interaction between folate and alcohol intake (P for interaction=0.1). When premenopausal women were excluded from the analyses and the analyses stratified by never-use or ever-use of hormonal replacement therapy, the association between folate intake and total or ischemic incidence of stroke remained nonsignificant.
|
| Discussion |
|---|
|
|
|---|
Our study did not have the power to compare extreme values of folate intake (>800 µg/d) in relation to risk of stroke, but ongoing clinical trials will be able to provide evidence on the relation of very high levels of supplemental intake and the risk of stroke. The possibility of a nonlinear relation between folate and stroke and the relatively few numbers of women with very low folate intake might explain our failure to detect such an association.
The hypothesized relation between folate and stroke is believed to be mediated by homocysteine levels,16,34 primarily because folate supplementation lowers homocysteine levels.14,15,35 There is evidence linking homocysteine with stroke,24,7 and 2 recent meta-analyses suggested that the risk of stroke might be reduced by 19% to 24% if serum homocysteine levels were lowered by 3 µmol/L,36,37 and a third meta-analyses found relative risk (RR) of 1.37 (95% CI: 0.99 to 1.99) of ischemic stroke among individuals with high homocysteine levels.38 However, 4 cohort studies have failed to find a significant positive association,1013 and this relationship was not evident even among folate-deficient patients in 1 study of subarachnoid stroke.39 More recently, a randomized controlled trial failed to find a difference in recurrence of stroke between low- and high-dose vitamin intake (folate, vitamin B6, and vitamin B12) through lowering of homocysteine levels.40
Most of the studies that have examined the direct relationship between folate and stroke were based on serum folate levels1719,34 and only 2 recent cohort studies assessed the intake of folate in relation to the risk of stroke.20,41 However, serum and dietary folate are well correlated. In the first National Health and Nutrition Examination Survey (NHANES 1) cohort,18 there was a small and nonsignificant elevation in the risk of stroke for those with folate serum levels
9.2 nmol/L compared with those with >9.2 nmol/L (RR=1.37; 95% CI: 0.82 to 2.29). The Bronx aging cohort study found no association between serum folate levels and incidence of stroke.17
In the Canadian Study of Health and Aging, Maxwell et al19 found an increased risk of cerebrovascular events (including vascular dementia, vascular cognitive impairment, and fatal stroke) among subjects in the lowest folate quartile compared with the highest quartile (odds ratio [OR]: 2.42; 95% CI: 1.04 to 5.61). After further follow-up of NHANES I, Bazzano et al20 used dietary intake of folate instead of serum folate levels and followed-up 9764 men and women aged 25 to 75 years for an average of 19 years, with 926 incident cases documented. They reported RR of 0.79 (95% CI: 0.63 to 0.99) comparing extreme quartiles, (P for trend=0.03). NHANES I used only baseline folate intake from the early 1970s using a single 24-hour recall questionnaire and did not update this intake during follow-up. In addition, the NHANES I sample size included men and women who were older in age compared with our study participants. Homocysteine may be a stronger risk factor for stroke in the elderly,35 which may explain their finding of a protective effect of folate intake. Another factor might be the lower median level of folate intake among the NHANES I (203 µg/d) compared with our median intake level (308 µg/d). Folate intake has increased among the US population since 1970, and a folate-deficient state associated with risk may be less common now. The other cohort study that used folate intake in relation to stroke was only among men.41 In that study, there was an inverse relation between folate intake and the risk of ischemic stroke, especially in the highest quintile (RR: 0.66; 95% CI: 0.45 to 0.98; P for trend=0.04). We have no explanation why folate was inversely related to ischemic stroke in men but not in women, but exposuredisease associations can vary by gender and further studies are needed to investigate this difference for the association between folate and stroke.
In conclusion, our results suggest that folate intake does not have an important relation to the risk of stroke in women. More results from clinical trials will shed further light on this relationship.42 Regular physical exercise, a diet rich in fruits, vegetables, and whole grains, not smoking, and other lifestyle modifications are likely to decrease the overall risk of cardiovascular diseases, including stroke; however, based on our results, there is no evidence for a benefit of folate supplementation in the context of the US diet.
| Acknowledgments |
|---|
Received January 19, 2004; revision received February 23, 2004; accepted March 2, 2004.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
S. C. Larsson, S. Mannisto, M. J. Virtanen, J. Kontto, D. Albanes, and J. Virtamo Folate, Vitamin B6, Vitamin B12, and Methionine Intakes and Risk of Stroke Subtypes in Male Smokers Am. J. Epidemiol., April 15, 2008; 167(8): 954 - 961. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ebrahim and M. Clarke STROBE: new standards for reporting observational epidemiology, a chance to improve Int. J. Epidemiol., October 1, 2007; 36(5): 946 - 948. [Full Text] [PDF] |
||||
![]() |
M. Folstein, T. Liu, I. Peter, J. Buel, L. Arsenault, T. Scott, and W. W. Qiu The Homocysteine Hypothesis of Depression Am J Psychiatry, June 1, 2007; 164(6): 861 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Lichtenstein and R. M. Russell Essential Nutrients: Food or Supplements?: Where Should the Emphasis Be? JAMA, July 20, 2005; 294(3): 351 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Van Guelpen, J. Hultdin, I. Johansson, B. Stegmayr, G. Hallmans, T. K. Nilsson, L. Weinehall, C. Witthoft, R. Palmqvist, and A. Winkvist Folate, Vitamin B12, and Risk of Ischemic and Hemorrhagic Stroke: A Prospective, Nested Case-Referent Study of Plasma Concentrations and Dietary Intake Stroke, July 1, 2005; 36(7): 1426 - 1431. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |